Breaking News Instant updates and real-time market news.

PCRX

Pacira

$36.10

0.2 (0.56%)

08:03
02/15/18
02/15
08:03
02/15/18
08:03

FDA Anesthetic and Analgesic Drug Products Advisory Committee meeting

Two day meeting, February 14-15, where the Committee discusses Pacira Pharmaceuticals' supplemental New Drug Application (sNDA) 022496/S-009 for EXPAREL, (bupivacaine liposome injectable suspension), to produce local analgesia and as a nerve block to produce regional analgesia will be held in Silver Spring, MD on February 15 at 8 Webcast Link

  • 15

    Feb

  • 21

    Feb

  • 06

    Apr

PCRX Pacira
$36.10

0.2 (0.56%)

01/19/18
GHSC
01/19/18
INITIATION
Target $51
GHSC
Buy
Pacira initiated with a Buy at Seaport Global
Seaport Global analyst Corey David initiated Pacira with a Buy and $51 price target. The analyst believes Exparel growth rates have bottomed and will begin to reaccelerate in 2018.
02/07/18
PIPR
02/07/18
NO CHANGE
Target $49
PIPR
Overweight
Piper 'cautiously optimistic' into Pacira FDA advisory panel
Piper Jaffray analyst David Amsellem remains "cautiously optimistic" on a favorable outcome into the FDA's Anesthetic and Analgesic Drug Products Advisory Committee meeting on February 14 and 15 to discuss Pacira Pharmaceuticals' supplemental new drug application filing for Exparel administration via upper and lower extremity nerve block. The analyst continues to believe that Exparel, even without a label expansion, is well positioned for "significant and sustainable" growth. He reiterates an Overweight rating on Pacira with a $49 price target.
02/12/18
BMOC
02/12/18
NO CHANGE
BMOC
Market Perform
BMO says Pacira briefing docs reveal 'several uncertainties' for Exparel
BMO Capital analyst Gary Nachman said his quick review of the FDA's analysis and draft questions for the upcoming advisory committee meeting reveal "several uncertainties" about Exparel in terms of consistency across studies and how the drug compares with IR bupivacaine. On efficacy, the FDA "appears to be cautious" about providing a broad label for nerve block, said Nachman, who keeps a Market Perform rating on Pacira shares.
02/13/18
PIPR
02/13/18
NO CHANGE
Target $49
PIPR
Overweight
Pacira briefing materials 'clearly a mixed bag,' says Piper Jaffray
Briefing materials for the upcoming meeting of the FDA's Anesthetic and Analgesic Drug Products Advisory Committee to discuss Pacira Pharmaceuticals' filing for Exparel administration via upper and lower extremity nerve block were "clearly a mixed bag," Piper Jaffray analyst David Amsellem tells investors in a research note. He believes this is not a surprise since the results of the studies supporting the filing were a "mixed bag." The analyst's read of the documents suggests that a label expansion in femoral nerve block is "likely off the table." That said, the documents did not focus significantly on the successful upper extremity study, and the voting questions clearly leave open the possibility of a narrow label expansion, Amsellem contends. He reiterates an Overweight rating on Pacira with a $49 price target.

TODAY'S FREE FLY STORIES

AAPL

Apple

$170.93

1.84 (1.09%)

, QCOM

Qualcomm

$58.09

0.36 (0.62%)

07:59
12/14/18
12/14
07:59
12/14/18
07:59
Periodicals
Apple will update Chinese iPhones to comply with Qualcomm ruling, Bloomberg says »

Apple (AAPL) will put out…

AAPL

Apple

$170.93

1.84 (1.09%)

QCOM

Qualcomm

$58.09

0.36 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:59
12/14/18
12/14
07:59
12/14/18
07:59
Conference/Events
The Cato Institute to hold a conference »

2018 Cato Institute…

EL

Estee Lauder

$140.08

1.4 (1.01%)

, COST

Costco

$226.41

-1.41 (-0.62%)

07:59
12/14/18
12/14
07:59
12/14/18
07:59
Recommendations
Estee Lauder, Costco analyst commentary  »

Estee enters club channel…

EL

Estee Lauder

$140.08

1.4 (1.01%)

COST

Costco

$226.41

-1.41 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

RNSDF

Renault

$0.00

(0.00%)

07:57
12/14/18
12/14
07:57
12/14/18
07:57
Periodicals
Renault board did not consider replacing Ghosn, Reuters says »

Renault's board did…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STWD

Starwood Property

$22.00

-0.055 (-0.25%)

07:55
12/14/18
12/14
07:55
12/14/18
07:55
Conference/Events
Starwood Property to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CNC

Centene

$132.85

-1.335 (-0.99%)

07:55
12/14/18
12/14
07:55
12/14/18
07:55
Conference/Events
Centene to hold a meeting »

2019 Financial Guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 05

    Feb

SGMS

Scientific Games

$15.77

-1.31 (-7.67%)

07:53
12/14/18
12/14
07:53
12/14/18
07:53
Recommendations
Scientific Games analyst commentary  »

Jefferies sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$80.82

-2.14 (-2.58%)

, DIS

Disney

$113.38

1.14 (1.02%)

07:53
12/14/18
12/14
07:53
12/14/18
07:53
Recommendations
Electronic Arts, Disney analyst commentary  »

Electronic Arts price…

EA

Electronic Arts

$80.82

-2.14 (-2.58%)

DIS

Disney

$113.38

1.14 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.90

0.8 (1.21%)

07:51
12/14/18
12/14
07:51
12/14/18
07:51
Recommendations
Starbucks analyst commentary  »

Starbucks earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HCSG

Healthcare Services

$42.60

-0.1 (-0.23%)

07:46
12/14/18
12/14
07:46
12/14/18
07:46
Recommendations
Healthcare Services analyst commentary  »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$48.51

0.08 (0.17%)

07:45
12/14/18
12/14
07:45
12/14/18
07:45
Recommendations
Activision Blizzard analyst commentary  »

Activision Blizzard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.39

-0.14 (-0.57%)

07:45
12/14/18
12/14
07:45
12/14/18
07:45
Recommendations
Bank of America analyst commentary  »

Bank of America shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

NKE

Nike

$72.94

-1.4 (-1.88%)

07:45
12/14/18
12/14
07:45
12/14/18
07:45
Recommendations
Nike analyst commentary  »

Tariff impact on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

KMX

CarMax

07:42
12/14/18
12/14
07:42
12/14/18
07:42
Recommendations
CarMax analyst commentary  »

Wedbush…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 21

    Dec

AMD

AMD

$19.86

-0.63 (-3.07%)

, NVDA

Nvidia

$148.88

-0.02 (-0.01%)

07:42
12/14/18
12/14
07:42
12/14/18
07:42
Recommendations
AMD, Nvidia analyst commentary  »

Mizuho cuts AMD target to…

AMD

AMD

$19.86

-0.63 (-3.07%)

NVDA

Nvidia

$148.88

-0.02 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 08

    Jan

  • 08

    Jan

SUP

Superior Industries

$5.94

-0.21 (-3.41%)

07:39
12/14/18
12/14
07:39
12/14/18
07:39
Hot Stocks
Superior Industries CEO Don Stebbins to retire »

Superior Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$170.93

1.84 (1.09%)

07:39
12/14/18
12/14
07:39
12/14/18
07:39
Periodicals
Notable Apple analyst cuts iPhone shipment estimate by 20%, CNBC says »

Demand for iPhones is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$34.90

2.765 (8.60%)

07:38
12/14/18
12/14
07:38
12/14/18
07:38
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$34.90

2.765 (8.60%)

07:36
12/14/18
12/14
07:36
12/14/18
07:36
Recommendations
Ciena analyst commentary  »

Ciena price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.39

-0.14 (-0.57%)

, C

Citi

$55.77

-0.22 (-0.39%)

07:35
12/14/18
12/14
07:35
12/14/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.39

-0.14 (-0.57%)

C

Citi

$55.77

-0.22 (-0.39%)

JD

JD.com

$22.71

0.81 (3.70%)

WFC

Wells Fargo

$47.03

-0.72 (-1.51%)

M

Macy's

$30.80

-1.0425 (-3.27%)

SBUX

Starbucks

$66.90

0.8 (1.21%)

CLF

Cleveland-Cliffs

$8.23

-0.135 (-1.61%)

MET

MetLife

$39.52

-0.05 (-0.13%)

NWL

Newell Brands

$22.78

-0.785 (-3.33%)

MRVL

Marvell

$15.64

0.29 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 06

    Jan

  • 08

    Jan

  • 14

    Jan

  • 15

    Jan

  • 12

    Feb

  • 12

    Apr

  • 15

    Apr

  • 18

    Jun

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

ICLR

Icon

$136.31

-1.83 (-1.32%)

07:34
12/14/18
12/14
07:34
12/14/18
07:34
Downgrade
Icon rating change  »

Icon downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.01

-0.29 (-1.90%)

07:33
12/14/18
12/14
07:33
12/14/18
07:33
Hot Stocks
Orchard Therapeutics, SIRION Biotech enter license agreement for LentiBOOST »

Orchard Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$16.33

-0.24 (-1.45%)

07:32
12/14/18
12/14
07:32
12/14/18
07:32
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GE

General Electric

$7.20

0.48 (7.14%)

, OSTK

Overstock.com

$17.97

-1.13 (-5.92%)

07:30
12/14/18
12/14
07:30
12/14/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$7.20

0.48 (7.14%)

OSTK

Overstock.com

$17.97

-1.13 (-5.92%)

GME

GameStop

$12.79

-0.445 (-3.36%)

ESRX

Express Scripts

$98.94

2.03 (2.09%)

CC

Chemours

$27.15

0.485 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
12/14/18
12/14
07:30
12/14/18
07:30
General news
Treasury Market Outlook: yields are dropped on risk-off flows »

Treasury Market Outlook:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.